Simple blood test could lead to personalized lung cancer treatment

medicalxpress - A single blood test could help doctors predict how lung cancer patients will respond to treatment before therapy begins, researchers have found. University of Queensland-led research focused on non-small cell lung cancer (NSCLC), the most common form of t…

AI Summary: Researchers describe a circulating cell-free methylated DNA liquid biopsy that can detect and track lung cancer by reading tumor-specific methylation patterns in blood. The minimally invasive test aims to guide personalized treatment choices, enable earlier detection of recurrence, and reduce dependence on tissue biopsies—basically doing the diagnostic heavy lifting while you sip your coffee.

• Blood-based lung cancer diagnostics and liquid biopsy (3)
• Policy, conferences and clinical practice shifts in lung cancer (4)
• Tumor plasticity and molecular drivers of resistance (3)
• All Other Stories

Blood-based lung cancer diagnostics and liquid biopsy

Policy, conferences and clinical practice shifts in lung cancer

Tumor plasticity and molecular drivers of resistance

All Other Stories